MedPath

Effect of a chitosan-chamomilla microparticle formulation in the prevention of radiation dermatitis

Phase 2
Conditions
Radiodermatitis
Breast cancer
Registration Number
RBR-9hnftg
Lead Sponsor
Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

18 years older; confirmed diagnosis of breast cancer; indication of radiotherapy treatment; Not having started radiation therapy; non-history of allergic reactions to any other component of chamomile or lanolin; non-history of allergic reactions to fish, shrimp or seafood; Kanofsky greater than 70; No use of systemic corticosteroids. do not use heparin, oral anticoagulants and antiplatelet agents.

Exclusion Criteria

Present any injury at the treatment site; present skin involvement by the tumor;

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath